| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dextromoramide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 10 mg/5 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 50 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 60 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 90 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| dihydrocodeintartrat 40 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Levacetylmethadol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Product containing methadone analog (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opiate agonist |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Remifentanil (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Dipipanone (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Methadone (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Alfentanil (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Oral fluid opiate level (procedure) |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Urine methadone metabolite level (procedure) |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Meptazinol (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Squill opiate (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opium alkaloid (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opioid intoxication delirium |
Causative agent |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Harmful pattern of use of opioid (disorder) |
Causative agent |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Product containing dihydrocodeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| opiater |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opioid-induced sexual dysfunction |
Causative agent |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Quantitative measurement of opiate agonist |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opioid intoxication |
Causative agent |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Opioid withdrawal |
Causative agent |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Product containing dextromoramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| Product containing opioid receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| acetylsalicylsyre + caffein + propoxyphenhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
| paracetamol + propoxyphennapsylat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Some |
|
FHIR